RACHEL PETRACCA, APRN
Women's Health Nurse Practitioner in PORTLAND, Maine. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: RACHEL PETRACCA, APRN filed 60 Medicare Part D claims in 2023 across PORTLAND, Maine. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
RACHEL PETRACCA, APRN at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Maine
How Women's Health Nurse Practitioner compares to other specialties among Maine providers
Women's Health Nurse Practitioner share within Maine
Women's Health Nurse Practitioner is one of the more visible NUCC categories in Maine
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Women's Health Nurse Practitioner (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Women's Health Nurse Practitioner ABMS/AOA estimate
Est. board-certified rate (Women's Health Nurse Practitioner) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Women's Health Nurse Practitioner US NPIs
Specialty board-certified rate — Women's Health Nurse Practitioner estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
RACHEL PETRACCA, APRN is a Women's Health Nurse Practitioner provider practicing in PORTLAND, Maine, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: APRN. NPI: 1063187151. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
RACHEL PETRACCA, APRN appears in the CMS NPPES registry as a Women's Health Nurse Practitioner provider holding APRN credentials at 84 MARGINAL WAY STE 900, PORTLAND, ME, 04101, with a listed phone of (207) 874-2445. NPI 1063187151 was issued on 08/11/2021. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PETRACCA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 60 prescription claims written by this provider, covering 28 Medicare beneficiaries and totaling roughly $7K in drug spend, split 18% brand-name and 82% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Women's Health Nurse Practitioner is a mid-sized specialty nationwide, with 9,452 enrolled providers across 55 states and an average of 262 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1063187151 |
|---|---|
| Specialty | Women's Health Nurse Practitioner |
| Credentials | APRN |
| Gender | Female |
| NPI Issued | 08/11/2021 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm RACHEL PETRACCA, APRN's current license status, disciplinary history, and board certifications with the Maine Board of Licensure in Medicine in Maine before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where RACHEL PETRACCA, APRN bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
18% brand-name claims vs 82% generic, on 60 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 118
- Total Day Supply
- 3,125
- Brand vs Generic
- 18% brand / 82% generic
- Brand Drug Cost
- $4K
- Generic Drug Cost
- $3K
Patient Demographics
- Average Patient Age
- 71.8 years
- Avg HCC Risk Score
- 0.71
- Gender Split
- 100% female / 0% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Estradiol | 23 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Women's Health Nurse Practitioner Overview
How RACHEL PETRACCA, APRN fits within the Women's Health Nurse Practitioner landscape nationally.
RACHEL PETRACCA, APRN's 60 claims are below the specialty average of 262.
Nearby Women's Health Nurse Practitioner Providers in Maine
Other clinicians with the same primary specialty enrolled in Maine, drawn from the same CMS NPPES roster as PETRACCA.
Compare Women's Health Nurse Practitioner nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Maine
Frequently Asked Questions
What is RACHEL PETRACCA, APRN's specialty? ▼
How much does RACHEL PETRACCA, APRN prescribe under Medicare Part D? ▼
Where is RACHEL PETRACCA, APRN located? ▼
What is RACHEL PETRACCA, APRN's NPI number? ▼
Does RACHEL PETRACCA, APRN prescribe more brand-name or generic drugs? ▼
How many Women's Health Nurse Practitioner providers are there in the US? ▼
What drugs does RACHEL PETRACCA, APRN prescribe most often? ▼
Does RACHEL PETRACCA, APRN accept Medicare? ▼
How can I verify RACHEL PETRACCA, APRN's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology